1.
Evaluation of treatment of HER2 positive Breast cancer patients with Trastuzumab combined with cytotoxic chemotherapy – a comparative study. TAJ: J of Teachers Assoc. 2018;26:30-37. doi:10.3329/taj.v26i0.37583